316 related articles for article (PubMed ID: 24444525)
1. Second cancer risk after 3D-CRT, IMRT and VMAT for breast cancer.
Abo-Madyan Y; Aziz MH; Aly MM; Schneider F; Sperk E; Clausen S; Giordano FA; Herskind C; Steil V; Wenz F; Glatting G
Radiother Oncol; 2014 Mar; 110(3):471-6. PubMed ID: 24444525
[TBL] [Abstract][Full Text] [Related]
2. Secondary cancer risk after whole-breast radiation therapy: field-in-field versus intensity modulated radiation therapy versus volumetric modulated arc therapy.
Haciislamoglu E; Cinar Y; Gurcan F; Canyilmaz E; Gungor G; Yoney A
Br J Radiol; 2019 Oct; 92(1102):20190317. PubMed ID: 31295011
[TBL] [Abstract][Full Text] [Related]
3. Hybrid planning techniques for early-stage left-sided breast cancer: dose distribution analysis and estimation of projected secondary cancer-relative risk.
Racka I; Majewska K; Winiecki J; Kiluk K
Acta Oncol; 2023 Aug; 62(8):932-941. PubMed ID: 37516978
[TBL] [Abstract][Full Text] [Related]
4. Left-sided breast cancer and risks of secondary lung cancer and ischemic heart disease : Effects of modern radiotherapy techniques.
Corradini S; Ballhausen H; Weingandt H; Freislederer P; Schönecker S; Niyazi M; Simonetto C; Eidemüller M; Ganswindt U; Belka C
Strahlenther Onkol; 2018 Mar; 194(3):196-205. PubMed ID: 28916844
[TBL] [Abstract][Full Text] [Related]
5. Secondary cancer risk after radiation therapy for breast cancer with different radiotherapy techniques.
Zhang Q; Liu J; Ao N; Yu H; Peng Y; Ou L; Zhang S
Sci Rep; 2020 Jan; 10(1):1220. PubMed ID: 31988348
[TBL] [Abstract][Full Text] [Related]
6. Critical Appraisal of the Risk of Secondary Cancer Induction From Breast Radiation Therapy With Volumetric Modulated Arc Therapy Relative to 3D Conformal Therapy.
Fogliata A; De Rose F; Franceschini D; Stravato A; Seppälä J; Scorsetti M; Cozzi L
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):785-793. PubMed ID: 29249528
[TBL] [Abstract][Full Text] [Related]
7. Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy.
Murray LJ; Thompson CM; Lilley J; Cosgrove V; Franks K; Sebag-Montefiore D; Henry AM
Phys Med Biol; 2015 Feb; 60(3):1237-57. PubMed ID: 25590229
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional conformal radiotherapy (3D-CRT) vs. volumetric modulated arc therapy (VMAT) in deep inspiration breath-hold (DIBH) technique in left-sided breast cancer patients-comparative analysis of dose distribution and estimation of projected secondary cancer risk.
Racka I; Majewska K; Winiecki J
Strahlenther Onkol; 2023 Jan; 199(1):90-101. PubMed ID: 35943553
[TBL] [Abstract][Full Text] [Related]
9. Treatment of left sided breast cancer for a patient with funnel chest: volumetric-modulated arc therapy vs. 3D-CRT and intensity-modulated radiotherapy.
Haertl PM; Pohl F; Weidner K; Groeger C; Koelbl O; Dobler B
Med Dosim; 2013; 38(1):1-4. PubMed ID: 22727550
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy-induced secondary cancer risk for breast cancer: 3D conformal therapy versus IMRT versus VMAT.
Lee B; Lee S; Sung J; Yoon M
J Radiol Prot; 2014 Jun; 34(2):325-31. PubMed ID: 24705154
[TBL] [Abstract][Full Text] [Related]
11. Risk evaluation of secondary malignancies after radiotherapy of breast cancer in light of the continuous development of planning techniques.
Cilla S; Deodato F; Romano C; Macchia G; Buwenge M; Boccardi M; Pezzulla D; Pierro A; Zamagni A; Morganti AG
Med Dosim; 2023 Winter; 48(4):279-285. PubMed ID: 37659968
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of 3D-CRT, IMRT and VMAT radiotherapy plans for left breast cancer based on clinical dosimetric study.
Liu H; Chen X; He Z; Li J
Comput Med Imaging Graph; 2016 Dec; 54():1-5. PubMed ID: 27838084
[TBL] [Abstract][Full Text] [Related]
13. Image-guided volumetric modulated arc therapy for breast cancer: a feasibility study and plan comparison with three-dimensional conformal and intensity-modulated radiotherapy.
Badakhshi H; Kaul D; Nadobny J; Wille B; Sehouli J; Budach V
Br J Radiol; 2013 Dec; 86(1032):20130515. PubMed ID: 24167182
[TBL] [Abstract][Full Text] [Related]
14. Estimation of radiation-induced secondary cancer risks for early-stage non-small cell lung cancer patients after stereotactic body radiation therapy.
Han C; Schultheiss TE; Wong JYC
Pract Radiat Oncol; 2017; 7(3):e185-e194. PubMed ID: 28089479
[TBL] [Abstract][Full Text] [Related]
15. Volumetric modulated arc therapy and breath-hold in image-guided locoregional left-sided breast irradiation.
Osman SO; Hol S; Poortmans PM; Essers M
Radiother Oncol; 2014 Jul; 112(1):17-22. PubMed ID: 24825176
[TBL] [Abstract][Full Text] [Related]
16. A dosimetric comparison of double-arc volumetric arc therapy, step-shoot intensity modulated radiotherapy and 3D-CRT for left-sided breast cancer radiotherapy after breast-conserving surgery.
Mo JC; Huang J; Gu WD; Gao M; Ning ZH; Mu JM; Li QL; Pei HL
Technol Health Care; 2017 Oct; 25(5):851-858. PubMed ID: 29103057
[TBL] [Abstract][Full Text] [Related]
17. The effect of intensity-modulated radiotherapy on radiation-induced second malignancies.
Ruben JD; Davis S; Evans C; Jones P; Gagliardi F; Haynes M; Hunter A
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1530-6. PubMed ID: 18207670
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric evaluation of 3-D conformal and intensity-modulated radiotherapy for breast cancer after conservative surgery.
Mansouri S; Naim A; Glaria L; Marsiglia H
Asian Pac J Cancer Prev; 2014; 15(11):4727-32. PubMed ID: 24969911
[TBL] [Abstract][Full Text] [Related]
19. Optimized volumetric modulated arc therapy versus 3D-CRT for early stage mediastinal Hodgkin lymphoma without axillary involvement: a comparison of second cancers and heart disease risk.
Filippi AR; Ragona R; Piva C; Scafa D; Fiandra C; Fusella M; Giglioli FR; Lohr F; Ricardi U
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):161-8. PubMed ID: 25863763
[TBL] [Abstract][Full Text] [Related]
20. Exposure of remote organs and associated cancer risks from tangential and multi-field breast cancer radiotherapy.
Simonetto C; Rennau H; Remmele J; Sebb S; Kundrát P; Eidemüller M; Wolf U; Hildebrandt G
Strahlenther Onkol; 2019 Jan; 195(1):32-42. PubMed ID: 30350118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
